GE HealthCare Technologies EBIT 2020-2024 | GEHC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

GE HealthCare Technologies 2023 EBIT was 2.435B, a 3.45% decline from 2022.
GE HealthCare Technologies 2022 EBIT was 2.522B, a 9.77% decline from 2021.
GE HealthCare Technologies 2021 EBIT was 2.795B, a 2.76% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

GE HealthCare Technologies 2023 EBIT was 2.435B, a 3.45% decline from 2022.
GE HealthCare Technologies 2022 EBIT was 2.522B, a 9.77% decline from 2021.
GE HealthCare Technologies 2021 EBIT was 2.795B, a 2.76% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

Related Stocks
Company Name	Market Cap
Tempus AI (TEM)	$7.9B
Inspire Medical Systems (INSP)	$6.2B
Axonics (AXNX)	$3.5B
Hims & Hers Health (HIMS)	$3.5B
10x Genomics (TXG)	$2.7B
Enovis (ENOV)	$2.4B
Azenta (AZTA)	$2.4B
Privia Health (PRVA)	$2.3B
IRhythm Technologies (IRTC)	$2.2B
Omnicell (OMCL)	$2B
Clover Health Investments (CLOV)	$1.5B
Schrodinger (SDGR)	$1.4B
Phreesia (PHR)	$1.4B
Standard BioTools (LAB)	$753M
Fulgent Genetics (FLGT)	$694M
Definitive Healthcare (DH)	$538M
Health Catalyst (HCAT)	$529M
Butterfly Network (BFLY)	$406M
Talkspace (TALK)	$343M
Pulmonx (LUNG)	$329M
SOPHiA GENETICS SA (SOPH)	$286M
TruBridge (TBRG)	$183M
P3 Health Partners (PIII)	$165M
American Well (AMWL)	$147M
Augmedix (AUGX)	$115M
EUDA Health Holdings (EUDA)	$90M
Future Health ESG (FHLT)	$65M
SHL Telemedicine (SHLT)	$55M
HeartBeam (BEAT)	$53M
111 (YI)	$51M